About the Brand Name Pharmaceutical Manufacturing in Delaware Market Research Report
What’s Included in the Brand Name Pharmaceutical Manufacturing in Delaware Market Research Report
Definition of the Brand Name Pharmaceutical Manufacturing in Delaware?
Brand name pharmaceutical manufacturers develop, produce and market pharmaceutical drugs under their proprietary brand names. These manufacturers often hold patents or other intellectual property rights to their drugs, granting them sole exclusivity to produce, distribute and sell their drug for the entire life of the patent.
What’s included in the Brand Name Pharmaceutical Manufacturing in Delaware?
The Brand Name Pharmaceutical Manufacturing in Delaware includes pharmaceutical research and development, manufacturing chemical pharmaceutical preparations and manufacturing biological pharmaceutical products. Related terms covered in the Brand Name Pharmaceutical Manufacturing in Delaware industry report includes a drug made from large-molecule living matter, as opposed to small-molecule chemicals, a drug derived from living organisms and marketed after the patent expiration of similar therapies. also known as flow-on biologics or biogenerics, a pharmaceutical or medicine designed to treat certain rare diseases, the period when numerous patents on blockbuster drugs are set to expire, to procure goods or services under contract with an outside supplier, medicines that may be sold directly to a consumer without a prescription from a healthcare professional, a blockbuster drug is a pharmaceutical product that generates significant revenue for its manufacturer, typically through high sales volume. blockbuster drugs are characterized by their ability to generate annual sales exceeding $1.0 billion or even several billion dollars, a strategy used by pharmaceutical companies to extend the patent life of a drug beyond its original expiration date by modifying or improving an aspect of the patented drug and a promising compound that has shown potential to treat a disease and is being tested in clinical trials to see if it’s safe and effective.
Industry Performance of the Brand Name Pharmaceutical Manufacturing industry in Delaware
Benchmark the Brand Name Pharmaceutical Manufacturing in Delaware industry performance with all DE county and national performance.
Brand Name Pharmaceutical Manufacturing in Delaware
#17 in Highest Revenue 1.6% of state's GDPRevenue (2025)
Annual Growth (2020-25)
Annual Growth (2025-30)
Brand Name Pharmaceutical Manufacturing in the US
Revenue (2025)
Annual Growth (2020-25)
Annual Growth (2025-30)
For the full list of industry drivers, see report purchase options.
Key Drivers of the Brand Name Pharmaceutical Manufacturing industry in Delaware
See how key industry drivers, such as population, new business formation, per capita disposable income, research and development expenditure, number of people with private health insurance and investor uncertainty are impacting Brand Name Pharmaceutical Manufacturing in Delaware
Delaware Economic Indicators
Population
New Business Formation
Per Capita Disposable Income
View more economic information in DE State Economic profile
US Key External Drivers
Research and development expenditure
Number of people with private health insurance
Investor uncertainty
For the full list of industry drivers, see report purchase options.
County Data of the Brand Name Pharmaceutical Manufacturing industry in Delaware
Access proprietary data on county in the Brand Name Pharmaceutical Manufacturing in Delaware, such as New Castle County, Sussex County and Kent County. Data includes figures on revenue, establishments, employees and wages by counties.
Key Statistics of the Brand Name Pharmaceutical Manufacturing industry in Delaware
Download 18 years of historical data and 5 years of projected performance.
